NumFin

Agenus Inc.

Symbol: AGEN

NASDAQ

13.07

USD

Market price today

  • -20.6369

    P/E Ratio

  • -0.6948

    PEG Ratio

  • 265.12M

    MRK Cap

  • 0.00%

    DIV Yield

Agenus Inc. (AGEN) Financial Statements

Download
AnnualQuarterly
LinearLog
On the chart you can see the default numbers in dynamics for Agenus Inc. (AGEN). Companys revenue shows the average of 38.956 M which is 1.212 % gowth. The average gross profit for the whole period is -7.675 M which is 0.410 %. The average gross profit ratio is -0.005 %. The net income growth for the company last year performance is -0.095 % which equals -0.270 % % on average for the whole company history.,

AnnualQuarterly
10Y20Y30Y40Y

Balance Sheet

Diving into the fiscal trajectory of Agenus Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.241. In the realm of current assets, AGEN clocks in at 112.416 in the reporting currency. A significant portion of these assets, precisely 76.11, is held in cash and short-term investments. This segment shows a change of -0.606% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 3.669, if any, in the reporting currency. This indicates a difference of 37.467% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 137.324 in the reporting currency. This figure signifies a year_over_year change of 3.466%. Shareholder value, as depicted by the total shareholder equity, is valued at -160.331 in the reporting currency. The year over year change in this aspect is 1.616%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 25.836, with an inventory valuation of 0, and goodwill valued at 24.72, if any. The total intangible assets, if present, are valued at 4.41. Account payables and short-term debt are 61.45 and 145.69, respectively. The total debt is 350.25, with a net debt of 274.14. Other current liabilities amount to 48.74, adding to the total liabilities of 462.3. Lastly, the referred stock is valued at 313.91, if it exists.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

balance-sheet.row.cash-and-short-term-investments

529.576.1193.4306.9
99.9
61.8
53.1
60.2
76.4
171.7
40.2
27.4
21.5
10.7
19.8
30.1
34.5
18.7
40.1
61.7
86.9
89.5
58.7
60.9
99.1
46.4

balance-sheet.row.short-term-investments

39.06014.715
0
0
0
0
5
35
14.5
0
0
0
0
10
10
4.2
15.9
28.5
70.9
32.3
25.6
0
3
0

balance-sheet.row.net-receivables

29.6225.82.71.5
1.2
16.3
0.9
1.1
11.4
9.8
1.2
0
0.6
0.5
0
0.8
0.6
0.3
0.2
0
0.1
0.6
1.1
0.5
0.5
0

balance-sheet.row.inventory

35.73013.820.4
10.7
7.4
0.1
0.1
0.1
0.1
0.1
0.7
0
0
0
0.3
0.2
0.5
0.4
0.3
0.2
0.9
1
1.4
0.7
0

balance-sheet.row.other-current-assets

19.5410.53.23.2
2
1
1.5
1.1
0.8
0.6
1.1
0.2
0
0.7
0.3
0.4
0.2
0.4
0.3
0.3
0.6
0.5
0.9
0.6
1.3
1.3

balance-sheet.row.total-current-assets

614.39112.4213.1332
113.8
86.5
74.8
73.6
91.3
184.1
42.7
28.2
22.6
12
20.9
31.5
35.5
20.8
42.3
67
92.6
93.3
63.4
64
101.6
47.7

balance-sheet.row.property-plant-equipment-net

678.07163164.391.1
60.3
33.7
25.1
26.2
25.6
15.3
6
5.6
5.2
4.1
6.2
8.9
11.5
14.6
18.6
23.4
25
25
11.4
13.9
14.6
8

balance-sheet.row.goodwill

99.7424.725.524.9
25.5
23.2
22.9
23
22.4
22.8
17.9
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2.6
2572.2
2572.2
3081.7
3081.7
0
0
0

balance-sheet.row.intangible-assets

19.554.46.28.5
10.9
10.5
12.3
31.8
16.4
18.8
6.8
0
0
0
0
1.6
3.3
3.5
4.6
2.6
9.4
11
3.1
2.8
3
0

balance-sheet.row.goodwill-and-intangible-assets

119.2929.131.733.4
36.3
33.7
35.3
54.8
38.8
41.6
24.6
2.6
2.6
2.6
2.6
4.2
5.8
6.1
7.2
2.6
9.4
11
3.1
2.8
3
0

balance-sheet.row.long-term-investments

12.683.72.72.7
2.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

-9.010-2.7-2.7
-2.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

30.415.74.59.5
4.1
1.4
1.2
1.2
1.3
1.3
1.2
1.3
1.3
1.1
1.3
1.3
4.1
3
4.8
11.2
6
10.7
11.2
12.9
8.8
0.3

balance-sheet.row.total-non-current-assets

831.44201.5200.4134
100.7
68.8
61.6
82.2
65.7
58.1
31.9
9.4
9.1
7.8
10.1
14.3
21.5
23.8
30.7
37.2
40.5
46.8
25.7
29.6
26.4
8.3

balance-sheet.row.other-assets

0000
0
0
0
-17.4
0
0
0
-2.8
3
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

1445.83313.9413.6466
214.5
155.3
136.4
138.4
157
242.2
74.5
34.8
34.7
19.8
30.9
45.9
56.9
44.5
73
104.2
133.1
140.1
89.1
93.5
128
56

balance-sheet.row.account-payables

201.5661.440.930.5
17
13.6
13.6
8.1
5.4
4.5
1.7
0.8
0.6
0.8
0.7
0.9
0.5
0.7
1.1
2.6
2.9
3.2
1.4
2.9
2.3
0.4

balance-sheet.row.short-term-debt

183.52145.72.53.4
2.8
2
0.1
20.6
0.1
0.1
1.3
3.5
0.2
0.2
0.1
0.1
0.1
0.1
0.1
4.1
5.4
5.6
0.5
5.9
2.3
0.8

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

363.62137.375.954.9
52.9
21.4
13.2
142.4
130.5
114.3
4.8
5.3
35.7
32.7
34.1
49.5
67.8
77.4
75.3
0
4.5
10.2
0
0.2
2.6
2.2

Deferred Revenue Non Current

4.571.11.111.2
28.3
27.7
1.2
7.7
12.3
15.1
3
3.2
4.8
2.1
3.6
3
3436.8
3038.3
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

67.23---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

441.4248.7133.2110.7
92.9
77.5
52.5
23.2
32.7
20.5
6.1
4.3
2.4
2.2
3
2.8
4.8
6.1
0.3
0.1
0
2
8
7.4
4
1

balance-sheet.row.total-non-current-liabilities

990.16206.4279.5261.1
296.1
264.5
242.9
157.8
155.3
142.6
42.3
29
41.9
35.9
40.2
57.5
73.9
83.2
81.3
53.1
7.4
12.7
1.3
1.4
2.7
2.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

291.367.265.344.7
36
9.4
0.1
0.3
0.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

1839.38462.3468.5418
426
386.7
310.9
214.2
196.1
171.5
51.5
39.3
46.7
40.6
45.6
62.8
80.9
91.6
90.3
72.3
26.6
34.8
11.3
17.6
11.3
4.3

balance-sheet.row.preferred-stock

0313.9413.6466
26.9
26.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

14.853.93.12.6
2
1.4
1.2
1
0.9
0.9
0.6
0.4
0.2
0.2
1.1
0.9
0.7
0.5
0.5
0.5
0.5
0.4
0.3
0.3
0.3
90

balance-sheet.row.retained-earnings

-7490.38-1955.7-1709.9-1489.8
-1465.9
-1285
-1177.3
-1026.5
-905.3
-779.2
-691.3
-649.1
-619
-607.7
-584.4
-562.5
-527.3
-498.6
-461.8
-410
-335.9
-279.7
-213.8
-157.9
-84.3
-37.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

-1.78-10.91.5
2.8
-1.3
-1.5
-2.2
-1.5
-2.1
-2
-27.6
-27.4
-26.1
-25
-28.6
-25.9
-22.6
0
-0.1
-0.2
0.1
-0.2
-0.7
-1.5
-0.7

balance-sheet.row.other-total-stockholders-equity

7036.141478.41231.11054.3
1230.6
1032.7
1005.2
951.8
866.9
851.1
715.7
671.9
628.6
607.1
593.6
573.2
528.6
473.7
444
441.5
442
384.5
291.4
234.2
202.3
0

balance-sheet.row.total-stockholders-equity

-441.17-160.3-61.334.4
-203.7
-225.4
-172.5
-75.8
-39.1
70.7
23
-4.5
-17.6
-26.4
-14.7
-17
-23.9
-47.1
-17.4
31.9
106.4
105.2
77.8
75.9
116.7
51.7

balance-sheet.row.total-liabilities-and-stockholders-equity

1445.83313.9413.6466
214.5
155.3
136.4
138.4
157
242.2
74.5
34.8
34.7
19.8
30.9
45.9
56.9
44.5
73
104.2
133.1
140.1
89.1
93.5
128
56

balance-sheet.row.minority-interest

47.6311.96.413.5
-7.8
-6
-2.1
0
0
0
0
0
5.6
5.6
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

-393.54-148.4-54.947.9
-211.5
-231.3
-174.5
-75.8
-39.1
70.7
23
-4.5
-12
-20.8
-14.7
-17
-23.9
-47.1
-17.4
31.9
106.4
105.2
77.8
75.9
116.7
51.7

balance-sheet.row.total-liabilities-and-total-equity

1445.83---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

46.43.714.715
2.6
0
0
0
5
35
14.5
0
0
0
0
10
10
4.2
15.9
28.5
70.9
32.3
25.6
0
3
0

balance-sheet.row.total-debt

614.37350.278.458.3
55.7
23.4
13.4
163
130.7
114.5
6
8.9
35.9
32.9
34.2
49.6
68
77.5
75.5
4.2
9.9
15.9
0.6
6.1
5
3

balance-sheet.row.net-debt

123.93274.1-100.2-233.6
-44.1
-38.4
-39.7
102.8
54.3
-57.2
-34.2
-18.5
14.4
22.2
14.4
29.6
43.5
63.1
51.3
-29
-6.1
-41.3
-32.6
-54.8
-91.2
-43.4

Cash Flow Statement

The financial landscape of Agenus Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -0.025. The company recently extended its share capital by issuing 133.96, marking a difference of 29.058 compared to the previous year. The company's investing activities resulted in net cash usage, amounting to 3400000.000 in the reporting currency. This is a shift of -1.101 from the previous year. In the same period, the company recorded 13.59, 0, and -8.93, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated 0 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as -0.61, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

cash-flows.row.net-income

-255.15-245.8-230.7-28.7
-182.9
-111.6
-162
-120.7
-127
-87.9
-42.5
-30.1
-11.3
-23.3
-21.9
-30.3
-28.7
-36.8
-51.9
-74.1
-68.8
-65.9
-55.9
-73.5
-46.7
-18.1

cash-flows.row.depreciation-and-amortization

13.5913.66.96.8
7.2
6.7
6.3
6
4.9
14.2
1.6
0.6
1.6
2.3
3.4
4.1
4.7
5.4
5.7
5.6
4.8
6.5
5.5
4.1
1.7
1

cash-flows.row.deferred-income-tax

-29.66-52.10-9.5
2.9
0.1
10.9
0
0
-5.4
0
2.7
0
23.3
-2
-2.3
-13.2
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

22.8722.918.319.6
10.4
9.9
7.6
12.4
13.2
7.4
4.7
4.1
4.3
2.6
3.2
3.1
5.6
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

10.7610.824.1-9.7
9
58.7
0.2
-6.5
10.4
6.6
-6
1.3
3.3
-2.1
0.4
-2.8
0.5
-0.4
-3.6
2
-0.4
6.7
-2.8
-3.3
1.7
-1.4

cash-flows.row.account-receivables

-23.46-23.50.1-0.4
16.2
-15.4
0.2
10.2
-1.5
-9.3
0
0.6
-0.6
0
0
-2.3
0.3
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

2.6300-6.2
3.6
0.1
0
0
17.6
0
-0.1
0
0
0
0.3
-0.1
0.3
-0.1
-0.2
-0.1
0.1
0
-0.2
-0.7
0.2
0

cash-flows.row.account-payables

21.3721.46.510.8
2.8
-0.2
5.4
1.6
0.4
2.7
0
0.2
-0.2
0
-0.2
0.3
-0.1
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

10.2212.917.5-14
-13.6
74.2
-5.4
-18.4
-6.1
13.3
-5.9
0.5
4
-2.1
0.3
-0.7
0.1
-0.4
-3.4
2
-0.5
6.7
-2.7
-2.6
1.4
0

cash-flows.row.other-non-cash-items

28.9526.55.931.7
14.3
17.6
6
14.5
18.5
17.8
4
1.8
3.1
-19.1
2.1
4
2.2
5.1
4.9
0.2
4.1
1.5
2.4
35.8
28.3
5

cash-flows.row.net-cash-provided-by-operating-activities

-208.64000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-4.56-10-53.1-33.8
-3.5
-4.7
-3.6
-3.1
-12.5
-3.6
-2.8
-0.8
-0.1
-0.1
-0.1
-0.2
-0.2
0
-0.3
-2.7
-4
-18.5
-2.3
-1.7
-2.6
-4.9

cash-flows.row.acquisitions-net

5.213.4-2.95.7
-1
0
0
0
0
-7.2
0.5
0
0
0
0
0.1
0
0
0
0
12.6
0
0
0
0
0

cash-flows.row.purchases-of-investments

-25.44-20-24.6-15
0
0
0
-14.9
-54.9
-35
-14.5
0
0
-5
-30
-30
-29.9
-11.2
-8.4
-100.9
-133.7
-57.2
-46.1
0
0
0

cash-flows.row.sales-maturities-of-investments

30.033025-5.7
0
0
0
20
85
14.5
0
0.5
0
5
40
30
24.1
24.4
21.1
143.4
126.1
50.5
20.5
3
0
0

cash-flows.row.other-investing-activites

21.160225.7
0
0
0
0.1
0
0
0
0
0
0
0.1
2.3
2
0
3
2
3
-7.3
-0.3
1.7
1
0

cash-flows.row.net-cash-used-for-investing-activites

3.43.4-33.6-43.1
-4.4
-4.7
-3.6
2.1
17.6
-31.2
-16.8
-0.4
-0.1
0
9.9
2.2
-4
13.2
15.4
41.8
3.9
-32.5
-28.2
3
-1.6
-4.9

cash-flows.row.debt-repayment

-8.93-8.9-0.5-1.3
-3.2
-0.3
-162.1
-0.3
-0.1
-1.1
-3.3
-10.6
-0.1
0
-6.2
-0.3
-2.9
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

133.1613499.2220.6
176.4
30
44.9
65.6
2.2
109.7
56.8
26.5
10.5
8
11.6
18.6
0.3
4.8
0.5
0.3
54.6
92.6
0.6
0.2
0.6
0

cash-flows.row.common-stock-repurchased

-4.33-4.6-3.8-1.7
0
0
0
-0.5
-0.7
0
-0.5
0
-0.6
0
0
-0.1
-0.3
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

000-9.1
0
0
0
-16
-1.2
0
-0.5
0
-0.6
-0.8
-0.8
-0.8
-0.8
-0.8
-0.8
-0.8
-0.8
0
0
0
0
0

cash-flows.row.other-financing-activites

0.29-0.60.916.7
10.7
1.6
245.5
31.8
-2.6
81
0.3
9.9
0.6
0.1
0
0.1
46.6
-0.3
20.9
42.3
-5.9
15.2
50.7
-1.7
65.9
42.6

cash-flows.row.net-cash-used-provided-by-financing-activities

119.87119.995.8225.3
183.9
31.3
128.3
80.5
-2.5
189.6
52.8
25.8
9.8
7.2
4.5
17.6
42.9
3.8
20.6
41.8
47.9
107.8
51.3
-1.4
66.5
42.6

cash-flows.row.effect-of-forex-changes-on-cash

-0.63-0.6-0.1-0.2
0.4
0.8
-0.7
0.4
-0.4
-0.2
0.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-101.56-102.6-113.3192.1
40.7
8.8
-7.1
-11.3
-65.3
111
-1.6
5.9
10.7
-9
-0.3
-4.4
10
-9.7
-9
17.2
-8.4
24.1
-27.7
-35.3
49.7
24.2

cash-flows.row.cash-at-end-of-period

499.4576.1181.3294.6
102.5
61.8
53.1
60.2
71.4
136.7
25.7
27.4
21.5
10.7
19.8
20.1
24.5
14.5
24.2
33.2
16
57.2
33.1
60.9
96.1
46.4

cash-flows.row.cash-at-beginning-of-period

601.01178.7294.6102.5
61.8
53.1
60.2
71.4
136.7
25.7
27.4
21.5
10.7
19.8
20.1
24.5
14.5
24.2
33.2
16
24.4
33.1
60.9
96.1
46.4
22.2

cash-flows.row.operating-cash-flow

-208.64-224.2-175.410.1
-139.1
-18.7
-131.1
-94.2
-80
-47.2
-38.2
-19.5
1
-16.2
-14.8
-24.2
-28.9
-26.7
-44.9
-66.3
-60.2
-51.2
-50.8
-36.8
-15.1
-13.5

cash-flows.row.capital-expenditure

-4.56-10-53.1-33.8
-3.5
-4.7
-3.6
-3.1
-12.5
-3.6
-2.8
-0.8
-0.1
-0.1
-0.1
-0.2
-0.2
0
-0.3
-2.7
-4
-18.5
-2.3
-1.7
-2.6
-4.9

cash-flows.row.free-cash-flow

-213.2-234.2-228.4-23.7
-142.6
-23.3
-134.7
-97.3
-92.5
-50.8
-41.1
-20.3
0.9
-16.3
-14.9
-24.4
-29.1
-26.7
-45.3
-69
-64.2
-69.7
-53.1
-38.5
-17.8
-18.4

Income Statement Row

Agenus Inc.'s revenue saw a change of 0.595% compared with the previous period. The gross profit of AGEN is reported to be 139.62. The company's operating expenses are 299.72, showing a change of 269.993% from the last year. The expenses for depreciation and amortization are 13.59, which is a -0.273% change from the last accounting period. Operating expenses are reported to be 299.72, which shows a 269.993% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.108% year-over-year growth. The operating income is -160.1, which shows a -0.108% change when compared to the previous year. The change in the net income is -0.095%. The net income for the last year was -245.76.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

income-statement-row.row.total-revenue

156.31156.398295.7
88.2
150
36.8
42.9
22.6
24.8
7
3
16
2.8
3.4
3.3
2.7
5.6
0.7
0.6
0.7
4.4
3.4
4.6
0.4
0.1

income-statement-row.row.cost-of-revenue

176.1616.7197.3182.1
145
168.3
124.6
116.1
95
70.4
22.3
13.5
11.2
0
0.1
0
0
0
0
0
0
1.9
1.3
1.1
-1.3
0

income-statement-row.row.gross-profit

-19.84139.6-99.2113.6
-56.8
-18.3
-87.8
-73.2
-72.4
-45.6
-15.4
-10.5
4.7
2.8
3.2
3.3
2.7
5.6
0.7
0.6
0.7
2.5
2.1
3.5
1.8
0.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

75.24---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

78.74---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

-5.2---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-1.490-175.1
-1.9
-168.3
-2.2
-16.9
-19.5
-7.2
0.8
-5.1
-4.6
0
0
0
0
0
0
0
0
0
0
0
1.7
1

income-statement-row.row.operating-expenses

140.26299.78176.4
59.2
46
37.3
33.7
33.1
28.4
21.3
14.5
11.5
21.8
25
31
40.5
38.8
49.9
74.5
67.5
70.2
59.4
45.1
28.4
18.9

income-statement-row.row.cost-and-expenses

316.42316.4278.3258.4
204.2
214.4
161.9
149.9
128.1
98.8
43.6
28
22.7
21.8
25.1
31
40.5
38.8
49.9
74.5
67.5
72.2
60.8
46.2
27.1
18.9

income-statement-row.row.interest-income

53.74061.965.7
61.1
41.5
0
0
0
0
0
0
0
0
0
0.1
0
1.5
1.9
2.8
1.5
1.2
1.6
3.4
6.2
0

income-statement-row.row.interest-expense

99.4597.961.965.7
61.1
41.5
25.3
18.9
17.3
6.6
1.3
2.4
4.7
4.2
4.9
5.3
5.1
5
3.3
3
0.5
0.2
0.4
0.7
0.4
0

income-statement-row.row.selling-and-marketing-expenses

-5.2---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-59.46-97.3-51.2-71
-65.7
-41.4
-11.6
-13.7
-21.5
-13.9
-5.9
-5.1
-4.6
0
4.7
-2.6
14.2
0
-1.2
0
-2.9
0.9
0.3
-34.6
-25.8
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-1.490-175.1
-1.9
-168.3
-2.2
-16.9
-19.5
-7.2
0.8
-5.1
-4.6
0
0
0
0
0
0
0
0
0
0
0
1.7
1

income-statement-row.row.total-operating-expenses

-59.46-97.3-51.2-71
-65.7
-41.4
-11.6
-13.7
-21.5
-13.9
-5.9
-5.1
-4.6
0
4.7
-2.6
14.2
0
-1.2
0
-2.9
0.9
0.3
-34.6
-25.8
0

income-statement-row.row.interest-expense

99.4597.961.965.7
61.1
41.5
25.3
18.9
17.3
6.6
1.3
2.4
4.7
4.2
4.9
5.3
5.1
5
3.3
3
0.5
0.2
0.4
0.7
0.4
0

income-statement-row.row.depreciation-and-amortization

13.2213.618.76.8
6.5
12.5
6.3
6
4.9
14.2
1.6
0.6
1.6
2.3
3.4
4.1
4.7
5.4
5.7
5.6
4.8
6.5
5.5
4.1
1.7
1

income-statement-row.row.ebitda-caps

-145.15---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-159.71-160.1-179.442.3
-117.2
-70.1
-123.8
-103.8
-107.5
-80.7
-43.3
-25
-6.7
-19.1
-21.8
-27.7
-37.8
-33.3
-50.6
-73.9
-69.7
-67.7
-57.4
-41.6
-26.7
-18.8

income-statement-row.row.income-before-tax

-257.44-257.4-230.7-28.7
-182.9
-111.6
-162
-120.7
-127
-87.9
-42.5
-30.1
-11.3
-24.1
-22.7
-31.6
-29.5
-52.7
-52.7
-74.9
12.6
-66.9
-57.1
-76.2
-52.5
0

income-statement-row.row.income-tax-expense

31.94-11.740.966
57.2
37.6
-12.9
-9.2
-3
-5.4
5.1
-0.6
-1.6
4.2
0.2
-1.5
-9.1
3.5
2.6
0.2
69.5
-1.8
-1.5
31.9
20
-0.7

income-statement-row.row.net-income

-249.77-245.8-271.5-94.7
-240.1
-149.1
-159.7
-120.7
-127
-87.9
-42.5
-30.1
-11.3
-23.3
-21.9
-30.3
-28.7
-36.8
-51.9
-74.1
-56.2
-65.9
-55.9
-73.5
-46.7
-18.1
Similar Stocks
You may also be interested in:
SRNE
Sorrento Therapeutics, Inc..
0.015 USD
NASDAQ
MRVI
Maravai LifeSciences Holdings, Inc..
8.97 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.03 USD
NASDAQ
GUBRA.CO
Gubra A/S.
300 DKK
CPH
T5O.DE
CytoTools AG.
0.468 EUR
XETRA
HBC.OL
Hofseth BioCare ASA.
2.1 NOK
OSL
6826.HK
Shanghai Haohai Biological Technology Co., Ltd..
42.35 HKD
HKSE
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ

Frequently Asked Question

What is Agenus Inc. (AGEN) total assets?

Agenus Inc. (AGEN) total assets is 313913000.000.

What is enterprise annual revenue?

The annual revenue is 108115000.000.

What is firm profit margin?

Firm profit margin is -0.127.

What is company free cash flow?

The free cash flow is -0.541.

What is enterprise net profit margin?

The net profit margin is -1.598.

What is firm total revenue?

The total revenue is -1.022.

What is Agenus Inc. (AGEN) net profit (net income)?

The net profit (net income) is -245761000.000.

What is firm total debt?

The total debt is 350246000.000.

What is operating expences number?

The operating expences are 299720000.000.

What is company cash figure?

Enretprise cash is 76110000.000.